Alpha 2.0
Login Register
» Authors » Amporn Limsalakpetch

Amporn Limsalakpetch

Explore the profile of Amporn Limsalakpetch including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 197
Followers 0
Related Specialties
Allergy & Immunology
General Medicine
Science
Top 10 Co-Authors
Sathit Pichyangkul
Kosol Yongvanitchit
Utaiwan Kum-Arb
Suwimon Wiboon-Ut
Anan Jongkaewwattana
Carl J Mason
Arunee Thitithanyanont
Mark M Fukuda
Anneke Engering
Rangsini Mahanonda
Published In
J Immunol
PLoS One
Biochem Biophys Res Commun
Am J Trop Med Hyg
Vet Immunol Immunopathol
Affiliations
Soon will be listed here.
Recent Articles
1.
Superior protection in a relapsing Plasmodium cynomolgi rhesus macaque model by a chemoprophylaxis with sporozoite immunization regimen with atovaquone-proguanil followed by primaquine
Yongvanitchit K, Kum-Arb U, Limsalakpetch A, Im-Erbsin R, Ubalee R, Spring M, et al.
Malar J . 2024 Apr; 23(1):106. PMID: 38632607
Background: To gain a deeper understanding of protective immunity against relapsing malaria, this study examined sporozoite-specific T cell responses induced by a chemoprophylaxis with sporozoite (CPS) immunization in a relapsing...
2.
Chemoprophylaxis with sporozoite immunization in P. knowlesi rhesus monkeys confers protection and elicits sporozoite-specific memory T cells in the liver
Pichyangkul S, Spring M, Yongvanitchit K, Kum-Arb U, Limsalakpetch A, Im-Erbsin R, et al.
PLoS One . 2017 Feb; 12(2):e0171826. PMID: 28182750
Whole malaria sporozoite vaccine regimens are promising new strategies, and some candidates have demonstrated high rates of durable clinical protection associated with memory T cell responses. Little is known about...
3.
Tissue Distribution of Memory T and B Cells in Rhesus Monkeys following Influenza A Infection
Pichyangkul S, Yongvanitchit K, Limsalakpetch A, Kum-Arb U, Im-Erbsin R, Boonnak K, et al.
J Immunol . 2015 Sep; 195(9):4378-86. PMID: 26408671
Studies of influenza-specific immune responses in humans have largely assessed systemic responses involving serum Ab and peripheral blood T cell responses. However, recent evidence indicates that tissue-resident memory T (TRM)...
4.
Pre-existing cross-reactive antibodies to avian influenza H5N1 and 2009 pandemic H1N1 in US military personnel
Pichyangkul S, Krasaesub S, Jongkaewwattana A, Thitithanyanont A, Wiboon-Ut S, Yongvanitchit K, et al.
Am J Trop Med Hyg . 2013 Nov; 90(1):149-52. PMID: 24277784
We studied cross-reactive antibodies against avian influenza H5N1 and 2009 pandemic (p) H1N1 in 200 serum samples from US military personnel collected before the H1N1 pandemic. Assays used to measure...
5.
Evaluation of in vitro cross-reactivity to avian H5N1 and pandemic H1N1 2009 influenza following prime boost regimens of seasonal influenza vaccination in healthy human subjects: a randomised trial
Bethell D, Saunders D, Jongkaewwattana A, Kramyu J, Thitithayanont A, Wiboon-Ut S, et al.
PLoS One . 2013 Apr; 8(3):e59674. PMID: 23555741
Introduction: Recent studies have demonstrated that inactivated seasonal influenza vaccines (IIV) may elicit production of heterosubtypic antibodies, which can neutralize avian H5N1 virus in a small proportion of subjects. We...
6.
Evaluation of the safety and immunogenicity in rhesus monkeys of a recombinant malaria vaccine for Plasmodium vivax with a synthetic Toll-like receptor 4 agonist formulated in an emulsion
Lumsden J, Pichyangkul S, Srichairatanakul U, Yongvanitchit K, Limsalakpetch A, Nurmukhambetova S, et al.
Infect Immun . 2011 Jun; 79(9):3492-500. PMID: 21690242
Plasmodium vivax is the major cause of malaria outside sub-Saharan Africa and inflicts debilitating morbidity and consequent economic impacts in developing countries. In order to produce a P. vivax vaccine...
7.
Antiviral immune responses in H5N1-infected human lung tissue and possible mechanisms underlying the hyperproduction of interferon-inducible protein IP-10
Thitithanyanont A, Engering A, Uiprasertkul M, Ekchariyawat P, Wiboon-Ut S, Kraivong R, et al.
Biochem Biophys Res Commun . 2010 Jul; 398(4):752-8. PMID: 20627090
Information on the immune response against H5N1 within the lung is lacking. Here we describe the sustained antiviral immune responses, as indicated by the expression of MxA protein and IFN-alpha...
8.
Cross-reactive Antibodies against avian influenza virus A (H5N1)
Pichyangkul S, Jongkaewwattana A, Thitithanyanont A, Ekchariyawat P, Wiboon-Ut S, Limsalakpetch A, et al.
Emerg Infect Dis . 2009 Oct; 15(9):1537-9. PMID: 19788839
No abstract available.
9.
Expression and function of Toll-like receptors on dendritic cells and other antigen presenting cells from non-human primates
Ketloy C, Engering A, Srichairatanakul U, Limsalakpetch A, Yongvanitchit K, Pichyangkul S, et al.
Vet Immunol Immunopathol . 2008 Jun; 125(1-2):18-30. PMID: 18571243
Antigen presenting cells (APCs), especially dendritic cells (DCs), play a crucial role in immune responses against infections by sensing microbial invasion through Toll-like receptors (TLRs). In this regard, TLR ligands...
10.
High susceptibility of human dendritic cells to avian influenza H5N1 virus infection and protection by IFN-alpha and TLR ligands
Thitithanyanont A, Engering A, Ekchariyawat P, Wiboon-Ut S, Limsalakpetch A, Yongvanitchit K, et al.
J Immunol . 2007 Oct; 179(8):5220-7. PMID: 17911607
There is worldwide concern that the avian influenza H5N1 virus, with a mortality rate of >50%, might cause the next influenza pandemic. Unlike most other influenza infections, H5N1 infection causes...